20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T1955 | SB225002 | CXCR | |
SB225002 is a potent and selective CXCR2 antagonist inhibiting interleukin IL-8 binding to CXCR2. | |||
T3047 | SRT3109 | CXCR | |
SRT3109 is a CXCR2 ligand used in the treatment of chemokine mediated diseases and conditions. | |||
T7681 | AZD-5069 | CXCR | |
AZD-5069 is an chemokine receptor 2 antagonist (CXCR2; IC50 = 0.79 nM). | |||
T1739 | WZ811 | CXCR | |
WZ811 is a novel and effective small molecular CXCR4 antagonist (EC50: 0.3 nM). | |||
T4163 | Reparixin | DF 1681Y,Repertaxin | CXCR |
Reparixin (Repertaxin) is a potent inhibitor of both CXCL8 receptors CXCR1/2, it inhibits weakly CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks CXCR1-mediated chemotaxis (IC50=1 nM). | |||
T3992 | MSX-122 | MSX 122,MSX122 | CXCR |
MSX-122 is a novel small molecule and partial CXCR4 antagonist, with potent inhibition of CXCR4/CXCL12 actions(IC50 = 10 nM). | |||
T17208 | USL311 | CXCR | |
USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4. USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing... | |||
T5193 | Danirixin | GSK1325756 | CXCR |
Danirixin (GSK1325756) is a potent antagonist of CXCR2 that inhibits IL-8 binding to CXCR2 (IC50: 12.5 nM). | |||
T10297L | AMG 487 | CXCR | |
AMG 487 is a potent and selective antagonist of chemokine (C-X-C motif) receptor 3 (CXCR3) which inhibits the binding of CXCL10 and CXCL11 to CXCR3 with IC50s of 8.0 and 8.2 nM, respectively. | |||
T2477 | UNBS5162 | UNBS 5162,UNBS-5162 | CXCR , Autophagy |
UNBS5162 (UNBS-5162) is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers. | |||
T9721 | ML339 | CXCR | |
ML339 a selective inhibitor of CXCR6(IC50 = 140 nM) with no response when screened against CXCR5 and CXCR4. | |||
T4033 | MSX-130 | MSX 130 | CXCR |
MSX-130 is CXCR4 Antagonist. | |||
T4032 | MSX-127 | MSX 127 | CXCR |
MSX-127 elicites positive response in peptide CXCR4. | |||
TQ0174 | Mavorixafor | AMD-070 | CXCR |
Mavorixafor (AMD-070) is an effective and selective antagonist of CXCR4, with an IC50 value of 13 nM against CXCR4 125I-SDF binding. Mavorixafor inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells (IC... | |||
T7499 | TAK-779 | Takeda 779 | HIV Protease , CXCR , CCR |
TAK-779 (Takeda 779) is an antagonist of chemokine receptor 5 (CCR5), CCR2b, and CXC chemokine receptor 3 (CXCR3). | |||
T8497 | SX-682 | CXCR | |
SX-682 is a potent, selective and orally bioavailable inhibitor of CXCR1/2 ,has the potential to treat castration-resistant prostate cancer. | |||
T16850 | SB-265610 | GSK-CXCR2 | CXCR |
SB-265610 (GSK-CXCR2) is a nonpeptide and allosteric CXCR2 antagonist. SB-265610 blocks rat cytokine-induced neutrophil chemoattractant-1 (CINC-1)-induced calcium mobilization and neutrophil chemotaxis (IC50s: 3.7 nM and... | |||
T3396 | Baohuoside I | Icariside-II,Icariin-II | Apoptosis , CXCR |
Baohuoside I (Icariside-II) is a component of Epimedium koreanum, exhibits anti-inflammatory activity and anti-osteoporosis activities. | |||
T11179 | Elubrixin | SB-656933 | IL Receptor , CXCR |
Elubrixin (SB-656933) inhibits neutrophil CD11b upregulation (IC50 of 260.7 nM) and shape change (IC50 of 310.5 nM). Elubrixin can be used for inflammatory diseases such as inflammatory bowel disease and airway inflammat... | |||
T7130 | Navarixin | MK-7123,SCH 527123 | CXCR |
Navarixin (MK-7123)(SCH527123) is a novel, selective CXC chemokine receptor 2(CXCR2) antagonist that inhibits neutrophil activation and modulates neutrophil trafficking in animal models, characteristics that may be benef... |